List of Oracle Life Sciences Clinical One Customers
Austin, 78741, TX,
United States
Since 2010, our global team of researchers has been studying Oracle Life Sciences Clinical One customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Oracle Life Sciences Clinical One for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Oracle Life Sciences Clinical One for Clinical Trial Management include: HCor Brazil, a Brazil based Healthcare organisation with 5342 employees and revenues of $225.0 million, Excelya, a France based Life Sciences organisation with 900 employees and revenues of $120.0 million, FHI Clinical, a United States based Life Sciences organisation with 450 employees and revenues of $44.0 million and many others.
Contact us if you need a completed and verified list of companies using Oracle Life Sciences Clinical One, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Oracle Life Sciences Clinical One customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Excelya | Life Sciences | 900 | $120M | France | Oracle | Oracle Life Sciences Clinical One | Clinical Trial Management | 2024 | n/a | In 2024, Excelya adopted Oracle Life Sciences Clinical One to standardize Clinical Trial Management for complex oncology and platform trials across Europe. The deployment prioritized data collection, randomization and trial supplies management to support the CRO's clinical operations and scale study delivery. The implementation used Oracle Life Sciences Clinical One EDC and RTSM capabilities, configured for electronic data capture, randomization workflows and trial supply lifecycle orchestration. The Clinical One EDC and RTSM modules were applied to study build and operational orchestration consistent with the Oracle case page description, supporting adaptive protocol elements common to platform trials. Operational coverage included clinical operations, data management and supplies management teams across multiple European sites. Governance emphasized standardized study build and go-live procedures and operational handoffs, which contributed to zero go-live failures and faster study delivery across Europe, enabling the CRO to scale operations and deliver numerous trials on time. | |
|
|
FHI Clinical | Life Sciences | 450 | $44M | United States | Oracle | Oracle Life Sciences Clinical One | Clinical Trial Management | 2025 | n/a | In 2025, FHI Clinical implemented Oracle Life Sciences Clinical One to manage electronic data capture and accelerate database builds for a large Phase 2b study. The deployment used Oracle Life Sciences Clinical One within the Clinical Trial Management category to support study delivery across global sites and centralize clinical data workflows. Implementation centered on electronic data capture and accelerated database build capabilities, with configurations to support study build automation and structured data management workflows. Oracle Life Sciences Clinical One was used to configure EDC forms, streamline database build cycles, and enable routine data validation and query management consistent with Clinical Trial Management processes. Operational coverage included FHI Clinical clinical operations and data management teams, and extended to the contract research organization supporting the Phase 2b study, with platform use at global investigator sites. Oracle s customer page reports faster adaptation to study requirements and improved efficiency for the CRO after adopting Clinical One, indicating a shift in how study changes and site data are handled. Governance emphasis focused on aligning study governance and operational workflows between FHI Clinical and the CRO, to support adaptive protocol updates and faster study delivery. Training and configuration governance were applied to maintain data quality standards and to ensure consistent use of Oracle Life Sciences Clinical One across study teams and sites. | |
|
|
HCor Brazil | Healthcare | 5342 | $225M | Brazil | Oracle | Oracle Life Sciences Clinical One | Clinical Trial Management | 2025 | n/a | In 2025, HCor Brazil implemented Oracle Life Sciences Clinical One, deploying the application in the Clinical Trial Management category to internally build and manage immunology clinical studies. The rollout explicitly uses Oracle Clinical One Data Collection for EDC and data collection workflows to centralize capture of clinical study data. Oracle Clinical One Data Collection was configured to support study build and electronic data capture, including form configuration, data validation rules, and study metadata orchestration, enabling internal teams to construct protocols and case report forms without engaging external study builders. The implementation leverages Clinical One capabilities for study build automation and integrated data management consistent with Clinical Trial Management functional workflows. The technical architecture is provisioned on Oracle Exadata Cloud@Customer to deliver on premise cloud performance and to improve IT performance as described in the vendor announcement. That infrastructure decision supports high throughput processing for EDC workloads and aligns application hosting with HCor IT operations. Operational scope focuses on immunology clinical studies, impacting clinical operations, data management, and IT, while governance shifted toward internal study build and vendor management to reduce reliance on third party vendors. Reported outcomes in the announcement include faster study build speed, improved IT performance, and lower study costs associated with internalizing EDC and study build activities. |
Buyer Intent: Companies Evaluating Oracle Life Sciences Clinical One
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||